Nuvo’s vision is to be the transformational leader in maternal fetal health. To begin to realize this vision, Nuvo is re-inventing Pregnancy Management, systemically, and developed a proprietary technology platform, INVU, designed to transform care delivery by making the mother “the point of care” and leveraging data to seamlessly connect visits across the home, the work place, the OB office, and the hospital environment. The INVU platform will enable a new practice of pregnancy population health management and deliver triple-aim measures in reducing costs, improving quality, and increasing both provider and patient satisfaction. INVU is protected with 11 core U.S. patents and 30 granted patents worldwide.
Nuvo is currently in the regulatory pathway with a 510k application and expect its first submission to be approved in Q4’2019. Focus in on the OB-GYN channel and select health systems during the adoption phase. To date, Letters of Intent (LOIs) have been secured from a leading U.S. integrated health system, an internationally renowned U.S. academic medical center, and a progressive HMO in Israel. With world-class board members, prestigious medical and business advisors, FDA clinical studies completed with impressive results, industry awards, and a substantial pre-launch global commercial pipeline, Nuvo is ready to capitalize on its innovation and unique market position.
Nuvo was founded by Oren Oz, a data scientist and entrepreneur in Israel’s high tech industry. His inspiration came from his personal experience when he and his wife endured the pain and uncertainty of managing a high risk pregnancy. This led Oren to a simple insight that became the basis for Nuvo’s innovations in pregnancy care: Data should travel, women should not! We must provide the next generation with a better way to manage pregnancy and truly give life a better beginning.